KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Capital Employed (2016 - 2025)

Edwards Lifesciences has reported Return on Capital Employed over the past 16 years, most recently at 0.11% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.11% for Q4 2025, down 1.0% from a year ago — trailing twelve months through Dec 2025 was 0.11% (down 1.0% YoY), and the annual figure for FY2025 was 0.11%, down 3.0%.
  • Return on Capital Employed for Q4 2025 was 0.11% at Edwards Lifesciences, down from 0.12% in the prior quarter.
  • Over the last five years, Return on Capital Employed for EW hit a ceiling of 0.25% in Q2 2021 and a floor of 0.11% in Q4 2025.
  • Median Return on Capital Employed over the past 5 years was 0.16% (2023), compared with a mean of 0.17%.
  • Peak annual rise in Return on Capital Employed hit 10bps in 2021, while the deepest fall reached -8bps in 2021.
  • Edwards Lifesciences' Return on Capital Employed stood at 0.23% in 2021, then fell by -13bps to 0.2% in 2022, then dropped by -17bps to 0.17% in 2023, then fell by -28bps to 0.12% in 2024, then decreased by -10bps to 0.11% in 2025.
  • The last three reported values for Return on Capital Employed were 0.11% (Q4 2025), 0.12% (Q3 2025), and 0.12% (Q2 2025) per Business Quant data.